NASDAQ:MYGN
Myriad Genetics
- Stock
Last Close
26.55
25/09 14:38
Market Cap
2.28B
Beta: 1.64
Volume Today
61.77K
Avg: 616.92K
PE Ratio
−6.54
PFCF: −13.02
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Jun '14 | Jun '15 | Jun '16 | Jun '17 | Jun '18 | Jun '19 | Jun '20 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 778.22M - | 723.10M 7.08% | 753.80M 4.25% | 771.40M 2.33% | 772.60M 0.16% | 851.10M 10.16% | 851.10M 0% | 557M 34.56% | 690.60M 23.99% | 678.40M 1.77% | |
cost of revenue | 109.20M - | 147.40M 34.98% | 157.30M 6.72% | 171.20M 8.84% | 177.20M 3.50% | 201M 13.43% | 201M 0% | 178.20M 11.34% | 197.60M 10.89% | 202M 2.23% | |
gross profit | 669.01M - | 575.70M 13.95% | 596.50M 3.61% | 600.20M 0.62% | 595.40M 0.80% | 650.10M 9.19% | 650.10M 0% | 378.80M 41.73% | 493M 30.15% | 476.40M 3.37% | |
selling and marketing expenses | |||||||||||
general and administrative expenses | 599.80M - | 514.70M 14.19% | |||||||||
selling general and administrative expenses | 327.10M - | 366M 11.89% | 359.10M 1.89% | 476.40M 32.66% | 467.10M 1.95% | 555.50M 18.93% | 555.50M 0% | 500.70M 9.86% | 599.80M 19.79% | 514.70M 14.19% | |
research and development expenses | 67.48M - | 75.50M 11.89% | 70.60M 6.49% | 74.40M 5.38% | 70.80M 4.84% | 85.90M 21.33% | 85.90M 0% | 80.90M 5.82% | 81.90M 1.24% | 85.40M 4.27% | |
other expenses | -1.97M - | 300K 115.20% | 1.20M 300% | -2.50M 308.33% | -400K 84% | 1.20M 400% | 1.20M 0% | 139.30M - | 600K 99.57% | ||
cost and expenses | 503.77M - | 588.90M 16.90% | 587M 0.32% | 722M 23.00% | 715.10M 0.96% | 842.40M 17.80% | 842.40M 0% | 831.50M 1.29% | 879.30M 5.75% | 802.10M 8.78% | |
operating expenses | 394.57M - | 441.50M 11.89% | 429.70M 2.67% | 550.80M 28.18% | 537.90M 2.34% | 641.40M 19.24% | 641.40M 0% | 653.30M 1.86% | 681.70M 4.35% | 600.10M 11.97% | |
interest expense | 6M - | 3.20M 46.67% | 12M 275% | 12M 0% | 6.60M - | 3.20M 51.52% | |||||
ebitda | 274.44M - | 159.20M 41.99% | 193.50M 21.55% | 96.40M 50.18% | 113.30M 17.53% | 86.10M 24.01% | 86.10M 0% | -123.40M 243.32% | 14.10M 111.43% | -67.80M 580.85% | |
operating income | 274.44M - | 134.20M 51.10% | 166.80M 24.29% | 49.40M 70.38% | 118.70M 140.28% | 7.60M 93.60% | 7.60M 0% | -194.80M 2,663.16% | -48.70M 75% | -123.70M 154.00% | |
depreciation and amortization | 13.82M - | 25M 80.91% | 26.70M 6.80% | 48.30M 80.90% | 54.40M 12.63% | 73M 34.19% | 73M 0% | 71.40M 2.19% | 62.80M 12.04% | 55.90M 10.99% | |
total other income expenses net | -1.97M - | 300K 115.20% | 1.20M 300% | -1.70M 241.67% | 60.80M 3,676.47% | 100K 99.84% | 100K 0% | -88.90M 89,000% | -8.40M 90.55% | -16.90M 101.19% | |
income before tax | 277.87M - | 134.90M 51.45% | 168.90M 25.20% | 42.90M 74.60% | 116.90M 172.49% | 7.70M 93.41% | 200K 97.40% | -283.70M 141,950% | -57.10M 79.87% | -140.60M 146.23% | |
income tax expense | 101.64M - | 54.70M 46.18% | 43.60M 20.29% | 21.30M 51.15% | -13.90M 165.26% | -4.40M 68.35% | -4.40M 0% | 59.90M 1,461.36% | -29.90M 149.92% | -28.60M 4.35% | |
net income | 176.22M - | 80.20M 54.49% | 125.30M 56.23% | 21.80M 82.60% | 131M 500.92% | 4.60M 96.49% | 4.60M 0% | -223.70M 4,963.04% | -27.20M 87.84% | -112M 311.76% | |
weighted average shs out | 75.73M - | 71.30M 5.85% | 70M 1.82% | 68.30M 2.43% | 69.40M 1.61% | 73.50M 5.91% | 73.50M 0% | 74.70M 1.63% | 77.71M 4.04% | 80.58M 3.68% | |
weighted average shs out dil | 78.18M - | 74.50M 4.71% | 73.40M 1.48% | 68.80M 6.27% | 72M 4.65% | 76M 5.56% | 76M 0% | 74.78M 1.61% | 78M 4.31% | 80.60M 3.33% | |
eps | 2.33 - | 1.12 51.93% | 1.79 59.82% | 0.32 82.12% | 1.89 490.62% | 0.06 96.83% | 0.06 4.33% | -2.99 4,876.36% | -0.35 88.29% | -1.39 297.14% | |
epsdiluted | 2.25 - | 1.08 52% | 1.71 58.33% | 0.32 81.29% | 1.82 468.75% | 0.06 96.70% | 0.06 0.83% | -2.99 5,042.15% | -0.35 88.29% | -1.39 297.14% |
All numbers in USD (except ratios and percentages)